117 related articles for article (PubMed ID: 38106097)
1. Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer.
Magnusson C; Augustsson P; Anand EU; Lenshof A; Josefsson A; Welén K; Bjartell A; Ceder Y; Lilja H; Laurell T
medRxiv; 2023 Dec; ():. PubMed ID: 38106097
[TBL] [Abstract][Full Text] [Related]
2. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis.
Augustsson P; Magnusson C; Nordin M; Lilja H; Laurell T
Anal Chem; 2012 Sep; 84(18):7954-62. PubMed ID: 22897670
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
Zeinali M; Lee M; Nadhan A; Mathur A; Hedman C; Lin E; Harouaka R; Wicha MS; Zhao L; Palanisamy N; Hafner M; Reddy R; Kalemkerian GP; Schneider BJ; Hassan KA; Ramnath N; Nagrath S
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947893
[TBL] [Abstract][Full Text] [Related]
5. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
6. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.
Chalfin HJ; Kates M; van der Toom EE; Glavaris S; Verdone JE; Hahn NM; Pienta KJ; Bivalacqua TJ; Gorin MA
Urology; 2018 May; 115():82-86. PubMed ID: 29432873
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
10. Impact of label-free technologies in head and neck cancer circulating tumour cells.
Kulasinghe A; Kenny L; Perry C; Thiery JP; Jovanovic L; Vela I; Nelson C; Punyadeera C
Oncotarget; 2016 Nov; 7(44):71223-71234. PubMed ID: 27655722
[TBL] [Abstract][Full Text] [Related]
11. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
12. Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.
Hassan S; Blick T; Thompson EW; Williams ED
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206049
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
[TBL] [Abstract][Full Text] [Related]
14. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
15. Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer.
Wang C; Zhang Z; Chong W; Luo R; Myers RE; Gu J; Lin J; Wei Q; Li B; Rebbeck TR; Lu-Yao G; Kelly WK; Yang H
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33450815
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy.
Yang G; Xie J; Zhang S; Gu W; Yuan J; Wang R; Guo C; Ye L; Peng B; Yao X; Yang B
Front Oncol; 2021; 11():812549. PubMed ID: 35127528
[TBL] [Abstract][Full Text] [Related]
18. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
19. A Review of Circulating Tumour Cell Enrichment Technologies.
Rushton AJ; Nteliopoulos G; Shaw JA; Coombes RC
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33652649
[TBL] [Abstract][Full Text] [Related]
20. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]